MediWound Announces Positive Results in U.S. Phase I/II Study of MW005 for the Treatment of Basal Cell CarcinomaRead More
Hedgehog Pathway Inhibitors Market to Expand at a Notable CAGR of ~11.1% Assessment for the Driving Factors, Size, Revenue, Segments, Expansion, Demand, and Opportunities During 2023-2033Read More
Including A Study of Urinary Stone Disease, Hypothyroidism, And Osteoporosis in Basal Cell Nevus PatientsRead More
Hamid Reviews Options for Patients With Basal Cell Carcinoma and Cutaneous Squamous Cell CarcinomaRead More
A 10-year follow-up on the chemopreventive role of photodynamic therapy in a Gorlin syndrome patientRead More
